Silymarin and milk thistle extract may prevent the progression of diabetic nephropathy in streptozotocin-induced diabetic rats

Renal Failure

Volumn 32, Issue 6, 2010, Pages 733-739

  Vessal, Ghazal ^a   Akmali, Masoumeh ^b   Najafi, Parisa ^c   Moein, Mahmood Reza ^c   Sagheb, Mohammad Mahdi ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidants; Diabetic nephropathy; Milk thistle extract; Rat; Silymarin

Indexed keywords

CATALASE; CREATININE; GLUCOSE; GLUTATHIONE PEROXIDASE; PROTEIN; SILYBUM MARIANUM EXTRACT; SILYMARIN; STREPTOZOCIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; DRUG MECHANISM; ENZYME ACTIVITY; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; KIDNEY PARENCHYMA; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; STREPTOZOCIN DIABETES; UREA BLOOD LEVEL;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; MALE; MILK THISTLE; PHYTOTHERAPY; PLANT EXTRACTS; PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SILYMARIN; STREPTOZOCIN;

EID: 77953570914     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2010.486488     Document Type: Article

References (40)

1. Bo S, Ciccone G, Rosato R, et al. Renal damage in patients with Type 2 diabetes: A strong predictor of mortality. Diabet Med. 2005;22(3):258-265.
2. Tarchini R, Bottini E, Botti P, et al. Type 2 diabetic nephropathy: clinical course and prevention proposals 2004. G Ital Nefrol. 2005;22 (Suppl 31):S15-19.
3. Gimeno Orna JA, Boned Juliani B, Lou Arnal LM, Castro Alonso FJ. Microalbuminuria and clinical proteinuria as the main predictive factors of cardiovascular morbidity and mortality in patients with type 2 diabetes. Rev Clin Esp. 2003;203(11): 526-531.
4. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes. 1991;40(4):405-412.
5. Ha H, Kim KH. Role of oxidative stress in the development of diabetic nephropathy. Kidney Int Suppl. 1995;51:S18-21.
6. Paolisso G, D'Amore A, Galzerano D, et al. Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type II diabetic patients. Diabetes Care. 1993; 16(11):1433-1437.
7. Ruiz C, Alegria A, Barbera R, Farre R, Lagarda MJ. Lipid peroxidation and antioxidant enzyme activities in patients with type 1 diabetes mellitus. Scand J Clin Lab Invest. 1999;59(2): 99-105.
8. Ruiz-Munoz LM, Vidal-Vanaclocha F, Lampreabe I. Enalaprilat inhibits hydrogen peroxide production by murine mesangial cells exposed to high glucose concentrations. Nephrol Dial Transplant. 1997;12(3):456-464.
9. Hunt JV, Bottoms MA, Mitchinson MJ. Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation. Some fundamental differences in proposed mechanisms of glucose oxidation and oxidant production. Biochem J. 1993;291(Pt 2):529-535.
10. Bierhaus A, Hofmann MA, Ziegler R, Nawroth PP. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res. 1998; 37(3):586-600.
11. Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu Rev Med. 1995;46:223-234.
12. Pradhan SC, Girish C. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian J Med Res. 2006;124(5):491-504.
13. Tesch GH, Allen TJ. Rodent models of streptozotocin-induced diabetic nephropathy. Nephrology (Carlton) 2007;12(3):261-266.
14. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
15. Newman D, Price C. Renal function and nitrogen metabolites. In: Burits CA, Ashwood ER, eds. Tietz Textbook of Clinical Chemistry. 3rd ed., Philadelphia: WB Saunders;1999.
16. Zal F, Mostafavi-Pour Z, Vessal M. Comparison of the effects of vitamin E and/or quercetin in attenuating chronic cyclosporine A-induced nephrotoxicity in male rats. Clin Exp Pharmacol Physiol. 2007;34(8):720-724.
17. Hagar HH, El Etter E, Arafa M. Taurine attenuates hypertension and renal dysfunction induced by cyclosporine A in rats. Clin Exp Pharmacol Physiol. 2006;33(3):189-196.
18. Fecondo JV, Augusteyn RC. Superoxide dismutase, catalase and glutathione peroxidase in the human cataractous lens. Exp Eye Res. 1983;36(1):15-23.
19. Aebi H. Catalase. In: Bergmeyer HU, ed. Methods of enzymatic analysis. 3rd ed., Weinheim: Verlag Chemie; 1983:273-286.
20. Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 1972;247(10):3170-3175.
21. Bors W, Saran M. Radical scavenging by flavonoid antioxidants. Free Radic Res Commun. 1987;2(4-6):289-294.
22. Bors W, Heller W, Michel C, Saran M. Flavonoids as antioxidants: determination of radical-scavenging efficiencies. Methods Enzymol. 1990;186:343-355.
23. Duthie G, Crozier A. Plant-derived phenolic antioxidants. Curr Opin Clin Nutr Metab Care. 2000;3(6):447-451.
24. Packer L, Rosen P, Tritschler H, King G, Azzi A. Antioxidants and diabetes management. New York: Marcel Dekker; 2000.
25. Evans JL, Goldfine ID. Alpha-lipoic acid: a multifunctional antioxidant that improves insulin sensitivity in patients with type 2 diabetes. Diabetes Technol Ther. 2000; 2(3):401-413.
26. Maddux BA, See W, Lawrence JC, Jr., Goldfine AL, Goldfine ID, Evans JL. Protection against oxidative stressinduced insulin resistance in rat L6 muscle cells by mircomolar concentrations of alpha-lipoic acid. Diabetes. 2001;50(2):404-410.
27. Anjaneyulu M, Chopra K. Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol. 2004;31(4):244-248. (Pubitemid 38507865)
28. Chakravarthy BK, Gupta S, Gode KD. Functional beta cell regeneration in the islets of pancreas in alloxan induced diabetic rats by (-)-epicatechin. Life Sci. 1982;31(24):2693-2697.
29. Sheehan EW, Stiff DD, Duah F, Slatkin DJ, Schiff PL, Jr., Zemaitis MA. The lack of effectiveness of (-)-epicatechin against alloxan induced diabetes in Wistar rats. Life Sci. 1983; 33(7):593-597.
30. Bone AJ, Hii CS, Brown D, Smith W, Howell SL. Assessment of the antidiabetic activity of epicatechin in streptozotocindiabetic and spontaneously diabetic BB/E rats. Biosci Rep. 1985;5(3):215-221.
31. Nuraliev Iu N, Avezov GA. The efficacy of quercetin in alloxan diabetes. Eksp Klin Farmakol. 1992;55(1):42-44.
32. Vessal M, Hemmati M, Vasei M. Antidiabetic effects of quercetin in streptozotocin-induced diabetic rats. Comp Biochem Physiol C Toxicol Pharmacol. 2003;135C(3):357-364.
33. Maghrani M, Zeggwagh NA, Lemhadri A, El Amraoui M, Michel JB, Eddouks M. Study of the hypoglycaemic activity of Fraxinus excelsior and Silybum marianum in an animal model of type 1 diabetes mellitus. J Ethnopharmacol. 2004;91(2-3): 309-316.
34. Vengerovskii AI, Khazanov VA, Eskina KA, Vasilyev KY. Effects of silymarin (hepatoprotector) and succinic acid (bioenergy regulator) on metabolic disorders in experimental diabetes mellitus. Bull Exp Biol Med. 2007;144(1):53-56.
35. Soto CP, Perez BL, Favari LP, Reyes JL. Prevention of alloxan-induced diabetes mellitus in the rat by silymarin. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1998;119(2): 125-129.
36. Li X, Cui X, Sun X, Li X, Zhu Q, Li W. Mangiferin prevents diabetic nephropathy progression in streptozotocin-induced diabetic rats. Phytother Res. 2009;(in press).
37. Singh J, Budhiraja S, Lal H, Arora R. Renoprotection by telmisartan versus benazepril in streptozotocin induced diabetic nephropathy. Iran J Pharmacol Thera. 2006;5(2): 135-139.
38. Mostafavi-Pour Z, Zal F, Monabati A, Vessal M. Protective effects of a combination of quercetin and vitamin E against cyclosporine A-induced oxidative stress and hepatotoxicity in rats. Hepatol Res. 2008;38(4):385-392.
39. Soto C, Recoba R, Barron H, Alvarez C, Favari L. Silymarin increases antioxidant enzymes in alloxan-induced diabetes in rat pancreas. Comp Biochem Physiol C Toxicol Pharmacol. 2003; 136(3):205-212.
40. Mira L, Silva M, Manso CF. Scavenging of reactive oxygen species by silibinin dihemisuccinate. Biochem Pharmacol. 1994; 48(4):753-759.